Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using lipid-lowering agents effectively. When diet is not enough.

D Scott1, M Kurenitz

  • 1Park Nicollet Medical Center, Minneapolis.

Postgraduate Medicine
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Less G(2) arrest in irradiated cells of breast cancer patients than in female controls: a contribution to their enhanced chromosomal radiosensitivity?

International journal of radiation biology·2003
Same author

Influence of intrinsic radiosensitivity on the survival of breast cancer patients.

International journal of radiation biology·2003
Same author

Non-linear dependence of interstitial fluid pressure on joint cavity pressure and implications for interstitial resistance in rabbit knee.

Acta physiologica Scandinavica·2003
Same author

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

Rheumatology (Oxford, England)·2003
Same author

Regulation of hyaluronan secretion into rabbit synovial joints in vivo by protein kinase C.

The Journal of physiology·2003
Same author

Presence and quantification of macrophages in squamous cell carcinoma of the cervix.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
See all related articles

Physicians can safely and effectively use lipid-lowering agents by understanding patient disorders and drug mechanisms. Long-term plans and follow-up are crucial for sustained benefits from altering lipid levels.

Area of Science:

  • Cardiology
  • Pharmacology
  • Metabolic Disorders

Background:

  • Lipid-lowering agents are essential for managing dyslipidemia.
  • Effective use requires understanding both patient-specific conditions and drug pharmacology.
  • Long-term management is key to realizing therapeutic benefits.

Purpose of the Study:

  • To outline the principles for safe and effective utilization of lipid-lowering therapies.
  • To emphasize the importance of physician knowledge in drug selection and patient management.
  • To highlight the long-term perspective required for successful lipid level alteration.

Main Methods:

  • Review of current pharmacological principles for lipid-lowering agents.
  • Analysis of the relationship between disease understanding and therapeutic outcomes.

Related Experiment Videos

  • Emphasis on the necessity of continuous patient monitoring and intervention strategies.

    • Main Results:

    • Safe and effective use of lipid-lowering agents is achievable with comprehensive physician understanding.
    • Therapeutic benefits of lipid level modification accrue over extended periods.
    • Short-term interventions without long-term planning yield minimal lasting results.

    Conclusions:

    • Physician education on lipid disorders and drug mechanisms is paramount for effective treatment.
    • A sustained, long-term approach with regular follow-up is critical for maximizing the benefits of lipid-lowering therapies.
    • The efficacy of lipid management hinges on a commitment to ongoing patient care and strategic intervention.